Transgenic organisms: should we use them or not?

Predicted values: how should we use them?

Controversies of surviving sepsis campaign bundles: should we use them?

Sepsis accounts for a huge number of deaths in intensive care units all over the world. In 2002, Surviving Sepsis Campaign (SSC) was launched, targeting a mortality reduction of 25% in 5 years. Treatment guidelines were developed, published in 2004 and revised in 2007. An educational program was initiated based on bundles in which 11 of those guidelines were put together to facilitate their ass...

Should we perform polypectomy or not?

Hong Kong Med J ⎥ Volume 20 Number 4 ⎥ August 2014 ⎥ www.hkmj.org A 78-year-old woman, with a known history of rheumatoid arthritis, complained of dizziness and was found to have iron-deficiency anaemia with a haemoglobin level of 105 g/L in January 2013. She was on treatment with methotrexate, sulphasalazine, and non-steroidal anti-inflammatory medications. Oesophagogastroduodenoscopy performi...

Newborn resuscitation: should we oxygenate or not?

HOW SHOULD WE OXYGENATE newborn and infants suffering from hypoxia and ischemia? Is it harmful to use 100% O2? It may seem odd to question a practice that has been carried out for so long, seemingly without any adverse effects. The case is, however, that after the practice of routinely using 100% O2 for newborn resuscitation was examined, many serious potentially harmful effects have to date be...

IgA deficiency: what we should-or should not-be doing.

Although IgA deficiency (IgAD) is currently recognised as the most frequent immunodeficiency in humans, individuals with IgAD are largely considered to be healthy and when discovered are usually not investigated further or followed up. The rare occasion when IgAD is a cause for concern is when these individuals require blood or blood products, in which case current practice advises that product...